Skip to main content
Home / Resources / On-Demand Webinar / The State of AI in In Silico Trials and Drug Development – The Practical Application of AI in QSP [APAC Webinar]

The State of AI in In Silico Trials and Drug Development – The Practical Application of AI in QSP [APAC Webinar]

April 18, 2024
On-Demand Webinar

The proliferation of AI models and GPTs has revolutionized how the life sciences industry consumes information and uses it for accelerating and validating research. By leveraging GPTs, researchers can complete what would normally be weeks long literature review and data extraction tasks in a matter of minutes or hours.

In this webinar, Certara’s experts will share novel approaches for leveraging AI to enhance data accessibility and analysis needed for drug development especially for QSP, PBPK, and MBMA. They will provide an educational overview on recent innovations in AI and the critical considerations that teams need to take to successfully deploy AI and GPT models within the life sciences. In addition, Piet will walk through benefits of AI for QSP with applications.

For whom the webinar will be beneficial the most:

  • Anyone engaging with QSP projects at pharmaceutical companies in Asia Pacific
  • Data Science experts who are interested in AI
  • Clinical pharmacologists or DMPK scientists who are interested in how to streamline a project workflow with AI

Webinar duration and time zone:

  • 60 minutes including Q&A
  • The webinar will take place in the APAC time zone – 2pm in China, and 3pm in Japan & Korea.

Speakers:

  • Nick Brown, Director, Global Portfolio Leader
  • Piet van der Graaf, Senior Vice President, Quantitative Systems Pharmacology
  • Amin Rostami, Chief Scientific Officer & VP, Research & Development